Enter inventor name

John S Driscoll

This inventor holds 18 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of, Government of the United States. Active years: 1977-2005.

USPTO Granted Patents = 18

% Patents Active = 94.4

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 162(Granted Patents)

Company Filing History:

10 out of 1,217

The United States of America as Represented by the Department of Health

patents

3 out of 2,202

The United States of America as Represented by the Secretary of

patents

1 out of 22

Government of the United States

patents

4. 1 out of 6

Institute of Molecular & Cell Biology

patents

5. 1 out of 28

The Government of the United States of America, as Represented by the

patents

6. 1 out of 255

The United States of America

patents

7. 1 out of 1

United States Government as Represented by the Secretary of the Dept. of

patent

Years Active: 1977-2005

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6841561 - Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases (2005-01-11),

2. 5817799 - 2'-Fluorofuranosyl derivatives and methods for preparing (1998-10-06),

3. 5565437 - 2',3'-dideoxy-2'-fluoro-purine nucleosides and methods for using same (1996-10-15),

4. 5498719 - Diastereoselective process leading to a key intermediate for the (1996-03-12),

5. 5495010 - Acid stable purine dideoxynucleosides (1996-02-27),

6. 5459256 - Lipophilic, aminohydrolase-activated prodrugs (1995-10-17),

7. 5336764 - 2'-fluorofuranosyl derivatives and novel method of preparing (1994-08-09),

8. 4992472 - Chemical differentiating agents (1991-02-12),

9. 4975434 - Antiviral and anticancer cyclopentenyl cytosine (1990-12-04),

10. 4968690 - 3-deazaneplanocin, intermediates for it, and antiviral composition and (1990-11-06),

11. 4882346 - Chemical differentiating agents (1989-11-21),

12. 4788181 - 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity (1988-11-29),

13. 4704384 - Aziridinyl quinone antitumor agents (1987-11-03),

14. 4275057 - Seven-membered ring compounds as inhibitors of cytidine deaminase (1981-06-23),

15. 4233215 - Aziridinyl quinone antitumor agents (1980-11-11),

Title: The Innovative Journey of John S. Driscoll

Introduction: John S. Driscoll, a pioneering inventor based in Rockville, MD (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: John S. Driscoll holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: With a career spanning over two decades, John S. Driscoll has been at the forefront of innovation, leading research and development teams in creating cutting-edge solutions for complex challenges.

Collaborations: Throughout his career, John S. Driscoll has collaborated with leading universities, research institutions, and tech companies to bring his inventions to life, fostering a culture of innovation and excellence.

Conclusion: John S. Driscoll's relentless pursuit of innovation and his passion for pushing the boundaries of technology have established him as a visionary inventor, shaping the future of various industries with his groundbreaking creations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]